Kamińska Dorota, Kościelska-Kasprzak Katarzyna, Chudoba Paweł, Mazanowska Oktawia, Banasik Mirosław, Żabinska Marcelina, Boratyńska Maria, Lepiesza Agnieszka, Korta Krzysztof, Gomółkiewicz Agnieszka, Dzięgiel Piotr, Klinger Marian
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wrocław, Poland.
Department of Vascular, General and Transplant Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wrocław, Poland.
Biomed Res Int. 2015;2015:797490. doi: 10.1155/2015/797490. Epub 2015 Jul 8.
Patients with renal failure suffer from immune disturbances, caused by uremic toxins and influenced by dialysis treatment. The aim of the present study was to reveal whether type of dialysis modality (hemodialysis, HD, versus peritoneal dialysis, PD) differentially affects the immunocompetence, particularly the expression of genes involved in the immune response.
87 renal transplant candidates (66 HD, 21 PD) were included in the study.
The peripheral blood RNA samples were obtained with the PAXgene Blood system just before transplantation. The gene expression of CASP3, FAS, TP53, FOXP3, IFNG, IL2, IL6, IL8, IL10, IL17, IL18, LCN2, TGFB1, and TNF was assessed with real-time PCR on custom-designed low density arrays (TaqMan). Gene expression data were analyzed in relation to pretransplant clinical parameters.
The mean expression of examined genes showed no significant differences between PD and HD with the exception of FAS, expression of which was 30% higher in PD patients compared to the HD group. There was nonsignificantly higher expression of proinflammatory cytokines in the PD group. The clinical inflammatory parameters (CRP, albumin, cholesterol, and hemoglobin levels) did not differ between the groups.
Type of renal replacement therapy exerts no differential effect on cytokine gene expression or inflammatory clinical parameters.
肾衰竭患者存在免疫紊乱,这是由尿毒症毒素引起并受透析治疗影响的。本研究的目的是揭示透析方式(血液透析,HD,与腹膜透析,PD)是否对免疫能力有不同影响,特别是参与免疫反应的基因表达。
87名肾移植候选者(66名HD,21名PD)被纳入研究。
在移植前,使用PAXgene血液系统获取外周血RNA样本。通过在定制设计的低密度阵列(TaqMan)上进行实时PCR,评估CASP3、FAS、TP53、FOXP3、IFNG、IL2、IL6、IL8、IL10、IL17、IL18、LCN2、TGFB1和TNF的基因表达。基因表达数据与移植前临床参数相关进行分析。
除FAS外,所检测基因的平均表达在PD和HD之间无显著差异,PD患者中FAS的表达比HD组高30%。PD组促炎细胞因子的表达略高,但无统计学意义。两组间临床炎症参数(CRP、白蛋白、胆固醇和血红蛋白水平)无差异。
肾脏替代治疗方式对细胞因子基因表达或炎症临床参数无差异影响。